How Bell Biosystems is using naturally magnetic bacteria to track cell therapies MBC Biolabs2015-11-23T23:28:12-08:00November 19th, 2015|In the Media|
Amarantus Announces Issuance of Australian Patent MBC Biolabs2018-09-25T12:32:48-07:00November 18th, 2015|Startup News|
Blueprint Genetics Plans to Boost Inherited Disease Panel Portfolio Next Year MBC Biolabs2015-11-18T22:56:07-08:00November 18th, 2015|In the Media|
Symic Biomedical Selects Osteoarthritis Clinical Candidate MBC Biolabs2018-09-25T12:36:26-07:00November 17th, 2015|Startup News|
A guy who hasn’t showered in 12 years just helped launch a skin care company MBC Biolabs2018-09-25T12:39:39-07:00November 16th, 2015|In the Media|
Symic Biomedical Advances First Product Candidate, SB-030, Into Clinical Development MBC Biolabs2016-06-29T21:16:27-07:00October 27th, 2015|In the Media|
Amarantus seeks US FDA orphan drug status for eltoprazine MBC Biolabs2018-09-25T12:49:30-07:00October 24th, 2015|Startup News|
Military researchers to conduct trial of Amarantus’s “engineered skin substitute” MBC Biolabs2016-06-29T21:16:48-07:00October 13th, 2015|In the Media|
Now You Can Buy Shampoo and Cleanser That Promote the Growth of “Good” Bacteria MBC Biolabs2015-07-09T18:29:54-07:00July 9th, 2015|In the Media|
